Inspirata
Inspirata Partners With UK Health Providers to Evaluate AI Software for Cancer Clinical Trials
The pilot programs will evaluate how artificial intelligence-based automation can improve matching patients with cancer to early-phase clinical trials.
In Brief This Week: Mirati Therapeutics, Gilead, Natera, Actinium Pharmaceuticals, Myriad Genetics
News items for the week of March 22, 2021.
Inspirata Partners With Carebox Healthcare on Automated Cancer Clinical Trial Matching
Carebox's system matches eligibility criteria from clinical trial databases with patients' health and genomic data to identify potentially relevant studies.